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ABSTRACT: Ligand binding is one of the most fundamental properties of
proteins. Ligand functions fall into three basic types: substrates, regulatory
molecules, and cofactors essential to protein stability, reactivity, or enzyme−
substrate complex formation. The regulation of potassium ion movement in
bacteria is predominantly under the control of regulatory ligands that gate the
relevant channels and transporters, which possess subunits or domains that
contain Rossmann folds (RFs). Here we demonstrate that adenosine mono-
phosphate (AMP) is bound to both RFs of the dimeric bacterial Kef potassium
eﬄux system (Kef), where it plays a structural role. We conclude that AMP binds
with high aﬃnity, ensuring that the site is fully occupied at all times in the cell.
Loss of the ability to bind AMP, we demonstrate, causes protein, and likely dimer,
instability and consequent loss of function. Kef system function is regulated via the
reversible binding of comparatively low-aﬃnity glutathione-based ligands at the
interface between the dimer subunits. We propose this interfacial binding site is itself stabilized, at least in part, by AMP binding.
A fundamental property of proteins, by which they expresstheir function in the cell, is the binding of ligands, usually
ions or molecules of small mass relative to that of the protein
itself. At least three diﬀerent roles are ascribed to the binding of
ligands. (1) The ligand is a substrate or essential cofactor for an
enzyme. (2) Ligand binding may be purely regulatory, bringing
about changes in protein activity. (3) Ligands may stabilize a
protein fold. The roles are not mutually exclusive and can be
combined. The activation of ligand-gated channels is usually
caused by an allosteric transition upon ligand binding at a point
distant from the pore; the changes in the concentration of the
ligand may reﬂect the biological state of either the cell or the
environment. Regulation of ion ﬂow is critical throughout
biology, and for potassium ions (K+), ligand-gated channels and
transporters are central to the modulation of cellular K+ pools.
In bacteria, both K+ channels, which play an important role in
K+ inﬂux and K+ eﬄux systems that control the response of the
bacterial cell to electrophiles, have K+ transport and NAD-
binding (KTN) domains. These domains may be covalently
attached to the pore or may be separately expressed entities that
form noncovalent associations with the pore. Some are hybrid
systems utilizing a combination of KTN domains that are part of
the integral pore-forming subunit together with KTN domains
expressed separately from an internal start codon on the same
mRNA as the pore protein.1,2 Another major structural variation
is that for the channels (e.g., TrkAH, KtrAB, and MthK)
octameric rings of KTN domains modulate ion ﬂux, whereas for
the Kef systems, dimeric assemblies dominate the known
architectures. A conserved feature of KTN domains is a
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Rossmann fold, a feature known to be associated with nucleotide
binding since its ﬁrst identiﬁcation in NAD(H)-binding lactate
dehydrogenase.3
In Escherichia coli, and most other bacteria, multiple transport
systems and channels eﬀect control over the K+ pool, including
the Kef systems, which are gated by glutathione (GSH) and its
electrophilic conjugates (GSX). In Gram-positive bacteria,
similar protective systems that employ electrophilic conjugates
of other species-speciﬁc thiols,4 for example, bacillithiol, might
exist.5−7 Whereas the activity of most K+ transport systems
causes modulation of the cytoplasmic pH in the alkaline
direction, the Kef systems cause acidiﬁcation in response to
cell-damaging electrophiles.8,9 The ∼600-residue Kef proteins
form dimers of an ∼380-amino acid membrane domain, which
may contain up to 12 transmembrane spans, although these are
poorly deﬁned from a structural perspective. A short hydrophilic
linker (20−26 amino acids) connects the membrane domain to
two further domains: an ∼150-residue KTN domain and a
further, less well-conserved, domain of variable length at the
extreme C-terminus of the protein. The KTN domains of
separate proteins dimerize, and the interface between them
contains the GSH-binding site. Gating of the K+ eﬄux system
requires GSH/GSX ligand-mediated communication between
the C-terminal domains and the loop containing the ion ﬂow-
regulating HALESDIEP sequence.10
The Kef proteins can be broadly divided into two classes, those
including E. coli KefC and KefB that require an ancillary protein
(KefF11 and KefG for KefC and KefB, respectively) for full
function and those, such as that from Shewanella denitrif icans,
that do not require an ancillary protein. Gating by GSH/GSX is
thought to be almost identical in both protein types. Residues in
the predicted GSX-binding site of S. denitrif icans Kef, identiﬁed
by sequence alignment andmodeling, will likely play roles similar
to that of their E. coliKefC counterparts, which were identiﬁed by
molecular genetic studies and crystallography. The E. coli KefC
protein has been diﬃcult to study biochemically because of the
instability of the KefF−KefC complex; thus, our studies have
focused on the simpler S. denitrif icans Kef protein.12
The Rossmann folds of the KTN domains in the K+ uptake
systems, TrkAH and KtrAB, have been studied biochemically
and shown by crystallography to bind ATP and NADH.13 These
uptake systems have K+-permeable pores with pseudo-4-fold
symmetry to create a pore reminiscent of the classical P-type K+
channels. Twin pores, arising from separate membrane proteins
in the dimer, form associations with an octameric assembly of
KTN domains. Binding of ATP and/or NADH modulates the
conformation of the octameric rings and regulates the opening of
the K+-conducting pore. ADP and NAD+ activate the GsuK
potassium channel, via its KTN-related RCK domains, whereas
Ca2+ serves as an allosteric inhibitor.14 In contrast, the structural
basis of regulation of other KTN domain-regulated K+ channels
(e.g., CglK, Kch, and MthK) by nucleotides is poorly
understood; although reversible gating by divalent cations has
been described for MthK, the role of nucleotide binding in the
RF is unknown.15 Similarly, for the GSX-gated Kef systems, the
role of the bound nucleotide is unclear.
Previously obtained X-ray crystal structures of the KTN
domain of TrkA from Methanocaldococcus jannaschii and the
KTN domain of KtrA from Bacillus subtilis have electron density
consistent with NADH bound in the Rossmann fold.13 On the
basis of these data, a homology model was constructed that had
NADH modeled into the Rossmann fold of Kef of the E. coli
KefFC KTN domain.13 In subsequent crystallographic studies of
the nucleotide pocket of the KTN domain of the E. coli KefFC
KTN domains,10 it is suggested that NADH occupies the
nucleotide-binding pocket based on the homology model and
the presence of this nucleotide in the crystallization liquor,
although only density that is consistent with a bound AMP
molecule exists. Subsequently, when structures with GSH and
GSX were determined, AMP was modeled into the GSH
structure, but no density consistent with a nucleotide was
observed in the GSX structure (density consistent with sulfate
ions was observed in the RF of the GSX structure).16 The
uncertainty over the identity of the bound ligand and the lack of
any insight into the role of the bound nucleotide prompted us to
re-examine the system in more detail.
Here we report the structural analysis of the KTN domain
from S. denitrif icans. We have established that both the isolated
ligand-binding C-terminal domain (SdKefCTD) and full-length
integral membrane protein (SdKef) contain AMP when puriﬁed
after overexpression in E. coli. Diﬀerential scanning ﬂuorimetry
(DSF, also known as thermal shift) analysis shows that
incubation of SdKefCTD with additional AMP results in major
stabilizing eﬀects on the protein. NADH, although it cannot
displace AMP from the KTN domain, results in some
stabilization in DSF studies. In the isolated soluble SdKefCTD
KTN domain, introduction of mutations predicted to aﬀect AMP
binding led to a lower level of protein expression, consistent with
a role for AMP in protein structural integrity. In agreement with
this proposal, molecular dynamics simulations indicate a reduced
stability of the SdKefCTD domain when AMP was removed. In
the full-length protein, the same mutations yielded inactive
channels. We propose that AMP is integral to the KTN domain
in SdKef and is required for the stable and functional Kef dimer
complex.
■ MATERIALS AND METHODS
Materials. n-Dodecyl β-D-maltopyranoside (DDM) was
purchased from Anatrace (www.aﬀymetrix.com). Glutathione
(reduced) (GSH), adenosine monophosphate (AMP), nicoti-
namide adenine dinucleotide (NAD+), and reduced nicotina-
mide adenine dinucleotide (NADH) were ordered from Fisher.
Reagents for buﬀer and other chemicals were purchased from
Sigma unless otherwise stated.
The chemicals, NaH2PO4 and Na2HPO4, were purchased
from Alfa Aesar and BDH Chemicals Ltd., respectively. Glycerol
and NaCl were purchased from Thermo Fisher Scientiﬁc Inc. All
other chemicals were purchased from Sigma-Aldrich Co. unless
otherwise speciﬁed. All of the buﬀers used in the puriﬁcation
procedures were preﬁltered through 0.2 μm pore size ﬁlter
papers (Sartorius UK Ltd.) under vacuum to remove insoluble
precipitates.
Expression and Puriﬁcation of Kef. The KTN construct,
denoted as SdKefQCTD, has been characterized previously and
contains residues 391−608 of the full-length SdKef protein,
including the KTN domain, the carboxy-terminal peripheral
domain, the highly charged Q-linker connecting the
SdKefQCTD with the transmembrane domains, and a peptide
corresponding to the regulatory HELEVDIEP loop, with a C-
terminal LEH6 tag.
12,25 The SdKefQCTD construct was
transformed into E. coli strain BL21(DE3) (www.bioline.com).
Cells were grown in 500 mL of LB medium at 37 °C to an OD600
of ≈0.8. The cultures were cooled to 25 °C and induced with 1
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 4 h. The
cell pellet was resuspended in lysis buﬀer, 50mMTris-HCl buﬀer
(pH 7.8), 300 mM KCl, 40 mM imidazole, 10% glycerol, and 1
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mM benzamidine. After disruption of the cells with a French
press at 18000 psi, the suspension was centrifuged at 4000g for 20
min to remove cell debris. The supernatant was then centrifuged
at 100000g for 1 h. The supernatant was then ﬁltered using 0.45
μm diameter ﬁlters and passed through a 25 mL column
containing 0.5 mL of nickel-nitrilotriacetic acid (Ni2+-NTA)
agarose, at 4 °C. The column was washed with 15 mL of wash
buﬀer, 50 mM Tris-HCl buﬀer (pH 7.8), 300 mM KCl, 50 mM
imidazole, 10% glycerol, and 1 mM benzamidine, to remove
nonspeciﬁcally bound proteins and was left at 4 °C overnight.
The next morning, the elution followed with 10 mL of elution
buﬀer, 50 mM Tris-HCl buﬀer (pH 7.8), 300 mM KCl, and 300
mM imidazole, and 0.5 mL fractions were collected. The
fractions were analyzed by sodium dodecyl sulfate−polyacryla-
mide gel electrophoresis (SDS−PAGE) and ultraviolet−visible
(UV−vis) absorption spectroscopy, and the fractions with the
highest protein content from the Ni2+-NTA columnwere applied
to a 120 mL Superose 6 column (General Electrics Healthcare)
equilibrated with buﬀer containing 50 mM Tris-HCl (pH 7.8)
and 300 mMKCl. Protein was then eluted at a ﬂow rate of 1 mL/
min. The protein concentration was monitored by absorption at
280 nm. The column was calibrated with Bio-Rad standards. The
identity and integrity were conﬁrmed by mass spectrometry
(Figure S3).
Alternative Protocol. E. coli strain MJF37312 was used to
express the SdKefQCTD protein construct, which is encoded in
the pTrcSdKefQCTDH6 plasmid.
12 The expression of the
SdKefQCTD protein can be induced by addition of IPTG. For
recombinant protein expression, the E. coliMJF373 host was ﬁrst
transformed with the pTrcSdKefQCTDH6 plasmid. The
resultant transformant was aerobically cultured in the 2× TY
medium [16 g/L Oxoid Tryptone (Thermo Fisher Scientiﬁc
Inc.), 10 g/L Oxoid Yeast Extract (Thermo Fisher Scientiﬁc
Inc.), and 5 g/L NaCl] at 30 °C with an agitation speed of 180
rpm in the presence of 100 μg/mL ampicillin (Apollo Scientiﬁc
Ltd.). When solid medium was required, Bacto Agar (BD) was
added to a ﬁnal concentration of 1.5% (w/v) in the 2× TY
medium.When the bacterial culture reached an optical density of
1.0 at 600 nm, IPTG (Apollo Scientiﬁc Ltd.) was added to a ﬁnal
concentration of 0.8 mM to induce expression of the
recombinant protein. Bacterial cell pellets were then harvested
by centrifugation (F10BCI-6x500y rotor, Avanti J-25 Centrifuge,
Beckman Coulter Inc.) at 11305g and 4 °C after IPTG
postinduction for 4 h and kept at −80 °C until protein
puriﬁcation. The SdKefQCTD protein was subsequently puriﬁed
by immobilized metal aﬃnity chromatography (IMAC) and then
size-exclusion chromatography (SEC) at 4 °C.
To prepare a sample for protein puriﬁcation, the frozen cell
pellet (7.70 g) was ﬁrst resuspended in extraction buﬀer.
Extraction buﬀer was prepared by completely dissolving one
tablet of SigmaFAST Protease Inhibitor Cocktail Tablet, EDTA
Free in 100 mL of a solution containing 50 mM NaH2PO4/
Na2HPO4, 500 mM NaCl, and 10% glycerol (pH 7.4). One
hundred milliliters of extraction buﬀer per 20 g of cell mass was
used for resuspension. After complete resuspension of the
bacterial pellets, the cells were lysed on ice by sonication (50%
amplitude, 5 s bursts interrupted by 5 s pauses for 60 cycles;
Ultrasonic Processor, Sonics & Materials, Inc.) to release
cytosolic proteins. Polyethylenimine at a ﬁnal concentration of
0.15% (v/v) was added from a 5% (v/v) stock solution (pH 7.4)
to the cell lysates, and the mixture was incubated on ice for 15
min to precipitate DNA. Insoluble cell debris and precipitated
DNA were removed by centrifugation (JA25.50 rotor, Avanti J-
25 Centrifuge, Beckman Coulter Inc.) at 25000g and 4 °C for 15
min. The resulting supernatant was collected and ﬁltered through
0.45 μm pore size syringe ﬁlters (Merck Millipore Corp.). The
clariﬁed cell lysate was diluted to 100 mL with extraction buﬀer
and then supplemented with 20 mM imidazole (Sigma-Aldrich
Co.) and 10 mM β-mercaptoethanol (Bio-Rad Laboratories,
Inc.) at their ﬁnal concentrations. This cell lysate preparation was
used for the ﬁrst step of protein puriﬁcation by IMAC.
For protein puriﬁcation by IMAC, a HisTrapHP 5mL column
(GE Healthcare) was used to purify hexahistidine-tagged
SdKefQCTD. The aﬃnity puriﬁcation columns were connected
to a computerized ÄKTAFPLC system (GE Healthcare). To
equilibrate the column for IMAC, 10 column volumes (CV) of
binding buﬀer [50 mM NaH2PO4/Na2HPO4, 500 mM NaCl,
10% glycerol, and 10 mM β-mercaptoethanol (pH 7.4)] was
used. The pretreated cell lysates (100 mL; from the sample
preparation procedure described above) were then loaded into
the equilibrated HisTrap HP column. After the sample had been
loaded into the column, binding buﬀer and elution buﬀer [50
mMNaH2PO4/Na2HPO4, 500 mMNaCl, 10% glycerol, and 500
mM imidazole (pH 7.4)] were mixed in diﬀerent ratios to wash
out nonspeciﬁcally bound proteins and elute the protein of
interest. First, 10 CV of a step gradient containing 9% elution
buﬀer (with 45 mM imidazole) and then a linear gradient from 9
to 30% elution buﬀer (containing ≤150 mM imidazole) over 10
CV were used to wash out contaminating binders. For elution of
the polyhistidine-tagged SdKefQCTD protein, 5 CV of 60%
elution buﬀer (containing 300 mM imidazole) was used to elute
the target in 2 mL fractions.
After the IMAC puriﬁcation step, SdKefQCTD was further
puriﬁed by SEC. The IMAC-puriﬁed SdKefQCTD protein was
ﬁrst concentrated by using a Vivaspin sample concentrator (GE
Healthcare). The concentrated protein sample (2 mL) was then
loaded via a 2 mL injection loop into an XK 16/70 gel ﬁltration
column (GE Healthcare) packed with 120 mL of Superdex 75
resin (GE Healthcare). This SEC column was pre-equilibrated
with 150 mL of degassed SEC buﬀer [50 mM NaH2PO4/
Na2HPO4 and 150 mM NaCl (pH 7.4)]. The SEC procedure
was performed at a constant ﬂow rate (1 mL/min) over 150 mL
of a total ﬂow volume, and ﬁltrates were collected in 5 mL
fractions (the sample collection was started at 20 mL and
stopped at 120 mL). The SEC-puriﬁed protein was further
concentrated by a Vivaspin sample concentrator (GE Health-
care) after the puriﬁcation process. Protein concentrations were
determined by a NanoDrop 1000 spectrophotometer (Thermo
Fisher Scientiﬁc Inc.).
Western Blot of Membrane and Soluble Fractions
Containing Full-Length SdKef or SdKefQCTD. Membrane
and soluble protein fractions were prepared from MJF373 cells
transformed with either pTrcSdKefH6 or pTrcSdKefQCTDH6.
Cells were culture overnight in LK medium (10 g/L tryptone, 5
g/L yeast extract, and 6.4 g/L KCl) with ampicillin (50 μg/mL)
and diluted the next morning to an OD650 of 0.05 into a fresh LK
medium as a preculture. Once cells had reached an OD650 of 0.4,
they were diluted 10-fold into fresh LKmedium and grown again
until an OD650 of 0.4 was reached, when 0.3 mM IPTG was
added for induction of expression for 30 min, after which 100 mL
of cells was harvested by centrifugation, resuspended in PBS
containing a protease inhibitor cocktail tablet (Roche), and lysed
by being passed through a French press at 18000 psi. Bulk cell
debris was removed by centrifugation for 10 min at 4 °C and
4500g, and membrane (pellet) and soluble fractions (super-
natant) were collected after ultracentrifugation at 90000g and 4
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°C for 60 min. The pellet was suspended in PBS, and Lowry26
estimation of the protein concentration was performed on the
pellet and supernatant. Samples were separated on 4 to 12%
Invitrogen NuPAGE Bis-Tris gels (ThermoFisher Scientiﬁc) run
in MES buﬀer using SeeBlue Plus 2 Marker. Proteins were
transferred onto nitrocellulose membranes and probed for
expression using an anti-His HRP conjugate antibody (Qiagen).
SuperSignal West Dura Extended Duration Substrate (Thermo-
Fisher Scientiﬁc) was used for ECL detection of bands, exposed
to Amersham Hyperﬁlm ECL ﬁlm (GE Healthcare) developed
on an M35 X-OMAT processor.
Expression and Puriﬁcation of the Full-Length SdKef
Protein. The full-length membrane protein was transformed
into E. coli strain BL21(DE3). Cells were grown the same as they
were for SdKefQCTD. The cell pellet was resuspended in 50mM
Tris-HCl buﬀer (pH 7.8), 300 mMKCl, and 1 mM benzamidine.
After disruption of the cells with a French press at 18000 psi, the
suspension was centrifuged at 4000g for 20 min to remove cell
debris. The supernatant was then centrifuged at 100000g for 1 h.
The pellet that contained the cell membrane was solubilized in
solubilization buﬀer [50 mM Tris-HCl buﬀer (pH 7.8), 300 mM
KCl, 1 mM benzamidine, 1.5% DDM, 10% glycerol, and 25 mM
imidazole] by using a homogenizer and left to gently shake for 1
h at 4 °C. The solubilized sample was subsequently passed
through a 25 mL column containing 0.5 mL of nickel-
nitrilotriacetic acid (Ni2+-NTA) agarose, at 4 °C. The column
was washed with 15 mL of wash buﬀer [50 mM Tris-HCl buﬀer
(pH 7.8), 300 mM KCl, 1 mM benzamidine, 0.05% DDM, and
35mM imidazole] to remove nonspeciﬁcally bound proteins and
was left at 4 °C overnight. The next morning, elution was
performed with 10 mL of elution buﬀer [50 mM Tris-HCl buﬀer
(pH 7.8), 300 mM KCl, 0.05% DDM, and 300 mM imidazole],
and 0.5 mL fractions were collected. The fractions were analyzed
by SDS−PAGE and UV−vis absorption spectroscopy, and the
highest fractions were applied to a 120 mL Superose 6 column
(General Electrics Healthcare) equilibrated with buﬀer contain-
ing 50 mM Tris-HCl buﬀer (pH 7.8), 300 mM KCl, and 0.05%
DDM. Protein was then eluted at a ﬂow rate of 1 mL/min. The
protein concentration was monitored by absorption at 280 nm.
The column was calibrated with Bio-Rad standards.
Structural Biology. SdKefQCTD was prone to aggregation
over an extended rage of concentrations required for structural
studies, but using stirred ultraﬁltration cell 8003 with a 30 kDa
membrane cutoﬀ (www.millipore.com) and a nitrogen stream at
4 °C prevented this, allowing a concentration of around 20 mg
mL−1, in buﬀer containing 50 mM Tris-HCl (pH 7.8) and 300
mM KCl. Crystal trials were set up by the hanging drop method
on freshly prepared protein samples that have not been
previously frozen and involved mixing 1:1 and 2:1 protein
solution:precipitant volumes equilibrated against a large volume
of precipitant. Crystals grew to full size dimensions of 0.2 mm ×
0.05 mm × 0.05 mm in ∼2.5 months at 21 °C. The best crystals
(judged by visual inspection) were obtained using 0.2 M sodium
malonate (pH 7.0) and 20% (w/v) PEG 3350 as a precipitant.
Prior to data collection, crystals were transferred into a solution
containing 0.2 M sodium malonate (pH 7.0) and 40% (w/v)
PEG 3350. Data were collected at 100 K on a single crystal, which
diﬀracted to a resolution of 2.92 Å on I24 at Diamond (Oxford,
U.K.). Data were indexed, integrated, and merged using
MOSFLM/SCALA [Leslie (1992) Joint CCP4 and ESF-
EAMCB newsletter on protein crystallography, No. 26, pp 1−10]
as implemented in CCP4 [CCP4 (1994) Acta Crystallographica
Section D 50, 760−763]. The resolution limits were determined
by the data statistics and the Wilson plot. The CCP4 program
POINTLESS was used to assign space groups for Kef as P42212.
The structure was determined using molecular replacement with
the program PHASER using E. coli KefC [Protein Data Bank
(PDB) entry 3EYW] as a model containing residues 410−570
(omitting all water molecules and ligands with nonconserved
residues set to alanine). AMP was modeled in both monomers,
and reﬁnement proceeded by REFMAC5 and manual inter-
vention COOT. Full crystallographic statistics are listed in Table
1.
Ligand Identiﬁcation. One hundred microliters of 200 μM
puriﬁed SdKefQCTD in 50 mM Tris-HCl (pH 7.8), 300 mM
KCl buﬀer and full-length puriﬁed SdKef in 50 mM Tris-HCl
(pH 7.8), 300 mM KCl, 0.05% DDM buﬀer were denatured by
being subjected to a constant temperature of 95 °C on a bench
thermo block for 30 min. The total volume of the sample
containing the denatured protein was loaded on a vivaspin
concentrator with a 3 kDa cutoﬀ and centrifuged at full speed on
a benchtop centrifuge until all liquid had gone through the
membrane (30 min). The ﬁltrate was loaded on a Superdex
Peptide 10/300 column (General Electrics Healthcare) with an
optimal size separation from 100 to 7000 Da. Prior to sample
loading, the column was equilibrated with buﬀer D. AMP, ATP,
and NADH in volumes of 100 μL and at concentrations of 2 mM
were individually loaded onto the same column on the same day,
under identical conditions to calibrate its behavior. The UV
active high-performance liquid chromatography (HPLC) peak
was subjected to matrix-assisted laser desorption ionization mass
spectrometry, as were the standards.
Nuclear Magnetic Resonance (NMR). NMR experiments
were performed at a 1H frequency of 600 or 700 MHz using a
Prodigy BBO probe (600 MHz) or Bruker Avance III
spectrometer equipped with a TCI inverse cryoprobe (700
MHz), respectively. The samples were prepared in 5 mm NMR
tubes and experiments conducted at listed temperatures. CPMG
experiments employed the PROJECT sequence (90°x−[τ−
Table 1. Statistics of the SdKefQCTD X-ray Crystal Structure
Data Collection
beamline Diamond_I24 (21/10/2012)
wavelength (Å) 0.9686
resolution (Å) 3.09 (47.6−3.09)
cell constants a = 71.6 Å, b = 71.6 Å, c = 140.4 Å,
α= β = γ = 90°
no. of unique reﬂections 6976 (399)
mean I/σ 15.3 (1.9)
completeness (%) 97.6 (85.8)
multiplicity 6.2 (3.3)
Rmerge 0.098 (0.651)
space group P41212
Wilson B-factor (Å2) 77
Reﬁnement
R (%) 20.53 (29.8)
Rfree (%) 26.04 (35.5)
PDB entry 5NC8
no. of atoms 2448
root-mean-square deviation for bond
lengths (Å)
0.01
root-mean-square deviation for bond
angles (deg)
1.558
Molprobity (S10) score 2.03 (99th percentile)
Clashscore, all atoms, score 5.43 (100th percentile)
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180°y−τ−90°y−τ−180°y−τ]n−acq) as described by Aguilar et al.
with a total ﬁlter time of 96 ms.27 In all edited 1H experiments,
water suppression was achieved by presaturation. Pulse tip angle
calibration was performed for all the samples using the Bruker
pulsecal routine.
The protein was prepared to a ﬁnal concentration of 330 μM in
deuterated sodium phosphate buﬀer as follows.
The puriﬁed protein solution was exchanged with deuterated
sodium phosphate buﬀer [50 mMNaH2PO4/Na2HPO4 and 150
mMNaCl (pH 7.4), which were prepared in deuterium oxide] by
using PD MiniTrap G-25 columns (GH Healthcare). The
exchange was performed by the spin protocol, according to the
manufacturer’s instructions.
The reference spectra of each of the ligands also were run at a
concentration of 330 μM in deuterated sodium phosphate buﬀer
[50 mM NaH2PO4/Na2HPO4 and 150 mM NaCl (pH 7.4),
which were prepared in deuterium oxide].
The protein was denatured on a heat block at 80 °C for 3 h.
Subsequently, the protein precipitate was centrifuged down and
the resultant supernatant used directly for NMR studies. The
ligands AMP, ADP, and NADH were heat treated in the same
manner as controls. The experiments were repeated without
removing samples from NMR tubes to conﬁrm AMP was not
observed from contamination.
Native Mass Spectrometry. Nanoelectrospray (nESI) MS
experiments were performed on a QToF-2 mass spectrometer
(Waters Corp., Wilmslow, U.K.) with conditions optimized for
the transmission of intact noncovalent protein complexes.18 The
sample was buﬀer exchanged into 200 mM ammonium acetate
and sprayed at a concentration of 7.5 μM with respect to the
dimer. Experiments were conducted at a positive polarity with
the following instrument settings: capillary, 1.4 kV; sample cone,
40 V; extraction cone, 25 V; backing pressure, 3.5 μbar; collision
cell pressure, 35 μbar. The instrument was calibrated using CsI,
and data analysis was performed usingMassLynx (Waters Corp.)
software. Protein masses were determined using the three most
intense charge states.
Diﬀerential Scanning Fluorimetry. Assays were per-
formed using a Stratagene Mx3005P qPCR instrument (Expt
ﬁlter set, excitation at 492 nm, emission at 568 nm). The initial
temperature was set to 25 °C (held for 5 min), increasing in
increments of 1 °C for 55 cycles (held for 90 s per cycle). Stock
solutions of the ligands under examination were prepared to a
concentration of 100 mM in buﬀer containing 50 mM sodium
phosphate and 150 mM NaCl (pH 7.4) [with the exception of
(−)-adenosine, which was prepared in dimethyl sulfoxide
(DMSO)]. The 100 mM stock solutions were then diluted to
a concentration of 10 mM in buﬀer containing 50 mM sodium
phosphate and 150 mM NaCl (pH 7.4). A protein master mix
was prepared containing SdKefQCTD (13.3 μM) and Sypro
Orange (2.2×, Invitrogen) in buﬀer containing 50 mM sodium
phosphate and 150 mM NaCl (pH 7.4). Ninety-six-well plates
(Axygen) were prepared using the protein master mix (22.5 μL
per well; ﬁnal protein concentration of 12 μM and ﬁnal dye
concentration of 2×) and the appropriate ligand (2.5 μL per well;
ﬁnal concentration of 1 mM). The plate was centrifuged at 1000
rpm for 3 min before being run. Controls were performed with
dye alone, ligand and dye, and the protein alone. The TM
(melting temperature) was identiﬁed by ﬁtting to the Boltzmann
equation (Prism 5).19 The change in unfolding temperature
(ΔTM) was calculated as the shift in TM relative to the TM of the
protein with 2.5 μL of buﬀer [DMSO in the case of
(−)-adenosine], in the absence of any ligand. A Student’s t test
was performed to ensure that the changes were statistically
signiﬁcant.
Expression and Puriﬁcation of Kef Mutant Construct
R416E SdKefQCTD. To express SdKefQCTD(R416E), the
pTrcSdKefQCTDH6-R416E plasmid was ﬁrst transformed into
E. coli strain MJF373.12 The expression and puriﬁcation
conditions were the same as those employed in the alternative
protocol for purifying the unmodiﬁed SdKefQCTD counterpart,
except medium LK [10 g/L Oxoid Tryptone (Thermo Fisher
Scientiﬁc Inc.), 5 g/L Oxoid Yeast Extract (Thermo Fisher
Scientiﬁc Inc.), 6.4 g/L KCl (Thermo Fisher Scientiﬁc Inc.), and
2 g/L glucose (Sigma-Aldrich Co.)] and a cell mass of 6.26 g
were used instead for protein expression and protein puriﬁcation,
respectively.
Quantiﬁcation of the Bound AMP Content in Proteins
by HPLC (R416E). Analytical HPLC was performed on a
PerkinElmer Flexar system with a binary LC pump and UV−vis
LC detector. A Dionex Acclaim 120 column (C18, 5 μm, 120 Å,
4.6 mm × 150 mm) was used to analyze the AMP content in
unmodiﬁed SdKefQCTD as well as its mutant counterpart,
SdKefQCTD(R416E). This HPLC analytic method had a
constant ﬂow rate of 1 mL/min and lasted for 20 min per run.
It adopted a mobile phase with a mixture of solvent A (99.9:0.1
H2O:formic acid ratio) and solvent B (99.9:0.1 MeCN:formic
acid ratio). This program employed 100% solvent A during the
ﬁrst minute and then increased the concentration of solvent B
from 0 to 100% over 10 min using a linear gradient, and this
100% solvent B concentration was held for a further 3 min until
the 14 min had passed. After that, the method decreased the
concentration of solvent B to 0% at 15 min, followed by 100%
solvent A running through the column for the last 5 min of the
experiment. The whole HPLC program is summarized in Figure
1.
We adopted an experimental procedure similar to that
developed by Chen et al.28 to analyze the bound AMP molecule
in proteins. To release the bound AMP, proteins of deﬁned
concentrations (10 μL) were ﬁrst heated at 95 °C in a dry heating
block for 5 min and then subjected to centrifugation at 13000
rpm for 10 min (MIKRO 20 Centrifuge, Hettich) to pellet down
denatured protein precipitates. The resultant pellet was
resuspended in 10 μL of SEC buﬀer [50 mM NaH2PO4/
Na2HPO4 and 150 mM NaCl (pH 7.4)], and the mixture was
then centrifuged at 13000 rpm for 10 min (MIKRO 20
Centrifuge, Hettich). The resulting supernatants from the two
centrifugation steps described above were combined (10 μL + 10
μL = 20 μL) and used as an injection sample for subsequent
Figure 1. Summary of the HPLC program.
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HPLC analysis. For the spikingHPLC experiments, supernatants
from the ﬁrst centrifugation step (10 μL) were combined with
AMP solutions (10 μL) of deﬁned concentrations.
Computational Methods. Molecular dynamics (MD)
simulations were performed using the SdKefQCTD model
previously built byHealy and co-workers.1 A total of four systems
were evaluated: (a) SdKefQCTD with gluthathione (GSH) and
two AMP molecules, (b) SdKefQCTD with ESG and two AMP
molecules, (c) SdKefQCTD with GSH, and (d) SdKefQCTD
with ESG. Molecular mechanics parameters for ESG, GSH, and
AMP were taken from the General AMBER Force Field
(GAFF)2 with AM1-BCC atomic charges. Hydrogen atoms
were removed from amino acid residues using the MolProbity
Server2 and added using tLeap.3 Glutamate and aspartate
residues were assigned as negatively charged and lysine and
arginine as positively charged. Minimization and MD calcu-
lations were performed using AMBER Force Field 12SB within
AMBER version 12 with the GPU-accelerated version of
PMEMD.4 Crystallographic waters were not removed, while
the protein was further solvated by a box of TIP-3P water
Figure 2. (A) X-ray crystal structure that shows SdKefQCTD as dimeric, with each nucleotide-binding pocket occupied by an AMP molecule (PDB
entry 5NC8). (B) View of the Kef protein looking from themembrane, in a surface view. AMP occupies both nucleotide-binding pockets and is depicted
as sticks (yellow carbons). (C) Two views of the Fo− Fc electron density map contoured at 3.0σ. The phases were calculated from a model that had not
included AMP. (D) The same Fo − Fc map now with the ﬁnal position of the AMP molecule shown as sticks.
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molecules.5 Simulations were performed in octahedral boxes
with an initial volume close to 160 nm3 containing 3060 water
molecules, adding countercations (Na+) to equilibrate the
system. Energy minimization was performed in two steps.
First, we used steepest descent followed by conjugate gradients
during which the initial positions of the small molecule inhibitor
and the protein structure obtained after homology modeling
were restrained (PR). Second, the same minimization method-
ology was performed without PR. The minimized macro-
molecule−small molecule(s) complex was then subjected to
equilibration for 500 ps and a production MD simulation for 40
ns in theNPT ensemble using a Langevin thermostat to simulate
a constant temperature at 310 K (τT = 0.1 ps). Previous work
performed by Zou,6 Hong,7 Shiao,8 and Gewert9 and their co-
workers showed that nanoscale MD could be enough to achieve
reasonable protein models obtained by homology modeling.
Isotropic position scaling was used to maintain a pressure of 1
atm (τp = 2 ps).
10 MD simulation was performed using a 1 fs
integration time and a nonbonding cutoﬀ of 8 Å, with the Shake
algorithm11 turned on to constrain bonds involving hydrogen. A
total of 2000 snapshots were obtained at intervals of 20 ps in
producing plots of the geometric variation during the simulation.
■ RESULTS
X-ray Crystal Structure of the C-Terminal Domain of
Kef from S. denitrif icans (SdKefQCTD). A construct of S.
denitrif icansKTN carboxy-terminal domains (SdKefQCTD) was
previously created to optimize stability and solubility.12 The
protein was puriﬁed to homogeneity from E. coli BL21(DE3) and
crystallized. So as not to bias the occupancy of the Rossmann
fold, no nucleotide was added before, during, or after puriﬁcation
or crystallization of the sample used for all crystallization trials.
Therefore, the presence of AMP in the crystal has arisen from
nucleotide binding inside the E. coli cell and subsequent co-
puriﬁcation. Optimization of initial sparse matrix crystallization
conditions yielded a single crystal for which diﬀraction data were
collected to 3.09 Å resolution (Table 1). The structure was
determined by molecular replacement using the apo-KefC
structure (PDB entry 3EYW) by removing NAD+ as the
searching model. The asymmetric unit contains two monomers
that form the canonical KTN dimer. In line with the PISA17
prediction, gel ﬁltration (Figure S1), size-exclusion chromatog-
raphy−multiangle laser scattering (SEC−MALS) (Figure S2)
analysis, and analytical ultracentrifugation (AUC) (Figure S3)
experiments indicated that the two Kef monomers form a stable
dimer in solution, at the concentrations used. The core fold of the
SdKefQCTD domain is essentially identical to that previously
described for the E. coli protein.10,16 Each monomer has six β-
strands (β1−6) arranged in a parallel sheet, which is sandwiched
between three α-helices on one face and one α-helix on the other.
Two C-terminal helices (α5 and α6), resolved in the structure,
form a helix−turn−helix-type arrangement and reach across to
the other monomer. The penultimate helix (α5) pairs with a
single helix (α1) from the other monomer and stacks against the
β-sheet from the other subunit. The long C-terminal helix (α6)
makes contacts with both monomers (Figure 2A).
Presence of AMP and Key Interactions in the KTN
Domain.Additional unbiased electron density was clearly visible
in both nucleotide-binding pockets (Figure 2A), which was best
ﬁtted and reﬁned with an AMP molecule. The nucleotide-
binding sites are located within the Rossmann fold of each
monomer, and the residues that contact AMP come from within
one monomer (Figure 2B). However, the phosphate groups are
only 12 Å apart and form part of a network of hydrogen bonds
that spans the dimer interface where GSH and GSX bind (Figure
S4). The side chain of R416 forms salt contacts with the
phosphate group of AMP within the same monomer (we
arbitrarily deﬁne as monomer A) and with E524 from the other
monomer (monomer B). E524 (B) in turn makes a further salt
bridge with R503 (B). R503 (B) binds to the AMP phosphate
group in monomer B. The net result can be considered an
octagon with vertices of α-phosphate (monomer A), R416 (A),
E524 (B), R503 (B), phosphate (B), R416 (B), E524 (A), and
R503 (A) (which links to the phosphate of monomer A) (Figure
3). R416 (A) also interacts with the backbone carbonyl oxygen of
I505 (B) from the opposite chain. I505 (B) is located at the
entrance to the previously identiﬁed GSH-binding pocket
(Figure S4). The B-factors observed in this region of the X-ray
crystal structure are below the mean for the whole protein,
indicating the region is well ordered consistent with it being rigid
and stable in the crystal form.
The adenosine of the AMP ring sits in a pocket formed by I478
and H437 with which it makes π-stacking interactions. The
aniline-like amine (N6) of the purine ring forms a hydrogen
bond with D456, and the adjacent pyridine-like nitrogen (N1)
atom forms a hydrogen bond with the backbone NH of A457
Figure 3. Two AMP-binding pockets of SdKefQCTD from S. denitrif icans (PDB entry 5NC8, AMP carbons colored yellow). The key residues involved
in AMP binding are highlighted as lines, with the residues from chain a shown with white carbons and the residues from chain b shown with green
carbons. The gray dotted line indicates the dimer interface.
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(Figure 4A). This pattern would appear to allow the protein to
distinguish between AMP and other nucleotides. O2 and O3 of
AMP are located close to D436, and O3 forms a hydrogen bond
with this residue. The structure points to a central role for the
phosphate group, which forms salt bridges to R416 and R503,
and hydrogen bonds to the backbone NH of R416 and F417.
Comparison with the X-ray crystal structure of the CTD of KefC
from E. coli, reported by Roosild et al., reveals that the key
residues involved in AMP binding are conserved between these
two proteins and form similar interactions with AMP (Figure
4B).16 An additional interaction between H434 of E. coli KefC is
visible, but the density for this residue is not well resolved in the
SdKefQCTD X-ray crystal structure.
Identiﬁcation of the Bound Nucleotide. Crystallography
on its own is not a reliable tool for identifying bound ligands.
Consequently, this technique cannot distinguish between AMP
and NAD+ with a disordered nicotinamide component. There-
fore, we performed HPLC analysis to identify the bound
nucleotide. Puriﬁed SdKefQCTD protein from the batch used
for crystallization trials was denatured and supernatant ﬁltered
through a 3 kDa cutoﬀ concentrator. The ﬁltrate was analyzed by
HPLC, and a peak with a retention time equal to that of an
authentic sample of AMP (distinct from ATP and NAD+) was
observed (Figure S5A). Further analysis by mass spectrometry
shows that the peak has a mass of 348 Da, corresponding to
protonated AMP (Figure S5A−C). Quantitation by UV
extinction coeﬃcient shows an AMP:protein ratio of at least
Figure 4.Comparison of the AMP-binding pocket of SdKefQCTD (A, PDB entry 5NC8, AMP carbons colored yellow) and the AMP-binding pocket of
the C-terminal domain of EcKefQCTD from E. coli (B, PDB entry 3L9W, AMP carbons colored orange).16 The key residues involved in AMP binding
are highlighted as lines and are conserved between the two proteins. The equivalent residue of H434 was not well resolved in the SdKefQCTD X-ray
crystal structure.
Figure 5.CPMG-edited 1H NMR spectra (700 MHz, 278 K) of the native (top) and denatured (middle) SdKefQCTD protein with the reference AMP
spectrum (bottom). The red stars denote resonances corresponding to AMP that appear in the SdKefQCTD protein spectrum after denaturation,
consistent with the release of AMP from SdKefQCTD following denaturation.
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0.6 (Figure S5A). Puriﬁed full-length integral membrane protein
S. denitrif icans Kef (expressed in E. coli) was treated in the same
way and gave the same result (Figure S5B,C) (n = 2).
1H CPMG NMR Analysis. A relaxation-edited 1H NMR
experiment was performed on both the native and denatured
SdKefQCTD protein using the Carr−Purcell−Meiboom−Gill
(CPMG)-based ﬁlter. This leads to suppression of the
background resonances that are derived from the protein and
attenuates those of any ligand bound to the macromolecule. The
native protein spectrum showed no resonances corresponding to
AMP (or NADH or ADP), conﬁrming that any nucleotide
present was tightly bound to the protein. However, when
SdKefQCTD was denatured by being heated for 3 h at 80 °C, a
new set of sharp signals was observed in the spectrum,
corresponding to the presence of a free AMP in solution (Figure
5). NADH and ADP were exposed to the same conditions used
to denature the protein (heating for 3 h at 80 °C) to formally
exclude the possibility that AMP was produced by breakdown of
NADH or ADP. Neither NADH nor ADP led to AMP
production (Figures S7 and S8), nor did the spectra of either
compound match those of the molecule detected. AMP was
stable to the same heat treatment (Figure S9).
Determining the Stoichiometry of Binding of AMP to
the SdKefQCTD Dimer. nESI MS measurements were then
performed to accurately determine the stoichiometry of AMP
binding under conditions that preserve noncovalent interactions
in the gas phase.18 The mass spectrum reveals a single charge
state series centered around 14+ corresponding to the dimeric
protein with two AMPmolecules bound (Figure 6A).We did not
detect apoprotein or a dimer with one AMP molecule bound,
indicating the protein is homogeneously and fully “loaded” with
AMP. Activation, achieved by accelerating the protein into a
collision cell,18 results in peaks corresponding to the mass of a
protein dimer with a single AMP molecule bound, and an apo
dimer (Figure 6 and Table S2). This is consistent with the
sequential loss of neutral AMP.
AMP Stabilizes SdKefQCTD. Given the regulatory roles
played by ATP (and NADH) in TrkAH and KtrAB, we sought to
investigate the inﬂuence of diﬀerent nucleotides on the stability
of SdKefQCTD in the presence and absence of the peptide
ligands GSH and ESG. We used DSF,19 in which the protein is
heated in the presence of a ﬂuorescent dye (SYPRO orange), and
as the protein unfolds, an increase in ﬂuorescence is observed.
The point at which the gradient of the ﬂuorescence increase is
greatest is the measured melting temperature of the protein
(Tm). Repeating the experiment in the presence of a ligand that
binds to, and hence stabilizes, a folded state of the protein results
in an increase inTm. The change in melting temperature between
the free and ligand-bound protein states (ΔTm) roughly
correlates to the ligand’s aﬃnity for the protein; however, there
are some caveats. In particular, larger ΔTm values are typically
observed for more entropically driven (e.g., hydrophobic)
binding. Therefore, it can be diﬃcult to directly compare ΔTm
values for compounds with very diﬀerent physicochemical
properties.20
We hypothesized that stabilization of the Kef Tm by AMP
would occur despite the protein being puriﬁed with a high
percentage of the nucleotide-binding sites occupied by AMP.We
assumed that as the temperature increases, and the protein
unfolds, the oﬀ rate of AMP would also increase, allowing the
stabilizing eﬀect of AMP binding to be observed. However, in the
presence of the exogenous AMP, the equilibrium would be
shifted, partially compensating for the increased oﬀ rate, resulting
in protein stabilization.
Conducting the DSF experiment in the presence of AMP
resulted in aΔTm of +15 °C (Figure 7A), which is consistent with
tight binding of AMP to SdKefQCTD. ADP showed aΔTm of +7
°C; ATP and adenosine had no eﬀect on Tm (Figure 7A),
suggesting that much of AMP’s aﬃnity for SdKefQCTD derives
from the binding of the phosphate group (Figure 7A). This
observation is consistent with the phosphate group−protein
interactions that were observed in the SdKefQCTD X-ray crystal
structure (Figure 4A) and our computational studies (see
below). NADH showed a ΔTm of +3 °C, but NADP and NAD+
had little eﬀect on Tm.
To compare the binding of the peptide and nucleotide ligands,
and to determine whether their binding was competitive, DSF
experiments in the presence of two ligands were conducted
(Figure 7B and Figure S10). It has previously been shown that
GSH has little eﬀect on Tm, which is consistent with its low
aﬃnity for SdKefQCTD.12 ESG, which has a higher aﬃnity for
SdKefQCTD, has a ΔTm of +7 °C. ESG binding was additive
with the other ligands (Figure S10); for example, the addition of
AMP and ESG gives a ΔTm of +18 °C. No release of AMP was
observed upon binding of the high-aﬃnity ESG analogue, tert-
butyl-S-glutathione (Figure S11), using CPMG NMR. These
data are consistent with structural data showing distinct
nucleotide- and peptide-binding sites.
Mutagenesis Studies for Probing the Role of AMP
When It Is Bound to the Rossmann Fold of SdKef and
SdKefQCTD. Mutation of three residues, R416, D436, and
H437, was performed in both SdKefQCTD and the full-length
protein to test our hypothesis that AMP binding was important
for protein stability and, thus, function. We selected H437
because it forms the top of the AMP-binding pocket and stacks
with the purine ring (Figure 8). D436 was identiﬁed to form
hydrogen bonds with the two hydroxyl groups on the ribose ring
of AMP (Figure 8) and R416 because it directly contacts the
AMP phosphate group (Figure 8). Our computational studies
(see below) predicted this to be a key interaction, and in general,
interactions between an arginine residue and a phosphate group
are typically strong21 and would be expected to contribute
signiﬁcantly to the binding interaction of Kef with AMP. The
SdKefQCTD mutants were expressed in E. coli strain MJF335,
which lacks the chromosomally encoded KefC and KefB proteins
and does not exhibit endogenous GSH biosynthesis because of
the disruption of the gshA locus. This strain permits the presence
of GSH to be controlled by medium supplementation. Whole
Figure 6. Determination of the stoichiometry of binding of AMP to
SdKefQCTD through native mass spectrometry. (A) Mass spectra of
SdKefQCTD reveal the sequential removal of two AMP molecules with
an increasing level of collisional activation. (B) Proportion of bound
SdKefQCTD, as a function of collision voltage, averaged across all
charge states.
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cell-based K+ eﬄux assays were performed with the full-length
mutant proteins expressed in MJF335 (KefB−, KefC−, GshA−)
supplemented during growth with 1 mM GSH (Table S3).
H437.H437 forms the top of the AMP-binding pocket and is
observed to be in the proximity (∼3.5 Å) of the purine ring of
AMP (Figure 8). It is, therefore, plausible that stacking
interactions between the two aromatic rings stabilize this
interaction. The H437A and M437N mutations remove the
stacking interactions and give an indication of how important this
residue is to the aﬃnity of SdKef for AMP. These mutations, in
either SdKefCTD or SdKef, had only limited eﬀects on protein
expression and function. Both H437A and H437N showed
expression levels similar to that of the wild-type protein in SdKef
(Figure 9A) and SdKefQCTD (Figure 9B). Consistent with the
expression data, full-length proteins carrying either H437A or
H437N were active in a K+ eﬄux assay, although both proteins
displayed altered kinetics; H437N exhibited close to wild-type
activity in its initial K+ loss rate, but the ﬁnal extent was reduced.
On the other hand, H437A displayed ∼50% of wild-type activity
in the initial rate of K+ lost, but the overall loss was similar to that
of the wild type. Taken together, these results indicate that the
purine ring of AMP contributes only modestly to its aﬃnity for
SdKef.
D436. D436 forms hydrogen bonds with the two hydroxyl
groups on the ribose ring of AMP (Figure 8). D436E would be
expected to form similar interactions with AMP. Consistent with
this hypothesis, the D436E mutant in both SdKef and
SdKefQCTD exhibited approximately wild-type expression
levels (Table 2 and Figure 9). The NEM-elicited eﬄux of K+
from the SdKef D436E mutant was not substantially altered from
that of the wild-type protein. The uncharged D436N would be
expected to form weakened hydrogen bonding interactions with
AMP, while D436A would be unable to form hydrogen bonds
with AMP. Both D436A and D436N displayed severely reduced
levels of protein expression in both SdKef and SdKefQCTD
Figure 7. (A) DSF experiments to determine the eﬀect of nucleotides on the stabilization of SdKefQCTD. It is shown that AMP is most eﬀective at
stabilizing SdKefQCTDwith aΔTm of +15 °C. (B) DSF experiments to determine the eﬀect of both AMP and ESG on the stabilization of SdKefQCTD.
Little stabilization is provided by GSH, whereas ESG shows aΔTm of +7 °C. The stabilization in the presence of both AMP and ESG is +18 °C, which is
consistent with separate binding sites for these two ligands.
Figure 8. AMP-binding residues that have been investigated by
mutagenesis studies are highlighted with purple carbons. AMP is
shown as a stick representation (yellow carbons). Image generated using
PyMOL and the X-ray crystal structure of SdKefQCTD (PDB entry
5NC8).
Figure 9.Western blot of the (A) full-length SdKef and (B) truncated SdKefQCTDmutants. The wild type (WT) and the mutants in each plasmid were
expressed in MJF373 cells and overproduced by induction with 0.3 mM IPTG. (A) Membrane fractions or (B) soluble fractions were isolated; 15 μg of
protein per well was separated via SDS−PAGE and transferred to a nitrocellulose membrane, and an antibody against the C-terminal His6 tag was used
for detection of the proteins. MJF373 alone was used as a control (Δkef).
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(Table 2); for SdKefQCTD D436N, no protein was detected
(Figure 9B). A signiﬁcant decrease in the K+ activity of the SdKef
D436A and D436N proteins was found, in line with the reduced
level of expression of these two mutant proteins (Figure 9A). A
low level of expression could indicate lower protein stability
resulting from impaired AMP binding.
R416. The R416A, R416M, and R416E mutations would be
expected to abolish phosphate binding. R416A shows low
expression levels for both the full-length [SdKef (Figure 9A)]
and truncated [SdKefQCTD (Figure 9B)] proteins. R416M also
showed low expression levels for SdKef and a reduced level of
expression for SdKefQCTD. These results are consistent with
themutations decreasing the level of binding of AMP to the KTN
domain. However, while R416E showed a very low level of
expression for SdKefQCTD (Figure 9B and Figure S12), the
mutated full-length SdKef protein showed wild-type expression
levels (Figure 9A). This observation implies that this mutant is
more stable in the full-length protein. While R416A retained
some activity in the K+ assay, R416M had substantially reduced
activity, and an R416E mutant was completely inactive,
consistent with the proposed hypothesis. While AMP might
still be accommodated in R416A, steric occlusion of the binding
site would be expected from R416M. R416E would likely be the
most disruptive to AMP binding, as the negatively charged γ-
carboxylate of glutamate would repel the phosphate group of
AMP. However, it is possible that protein folding is better in the
full-length protein than in the truncated construct. Once folded,
it is possible that E416 forms a salt bridge with R503, stabilizing
the protein while not binding AMP, explaining the stable but
inactive protein.
HPLC Analysis of AMP Retention by the Mutated
Proteins.To determine whether the variation in protein stability
and function correlated to the degree of AMP binding, we used
HPLC analysis to assess the amount of AMP that was co-puriﬁed
with the mutated proteins (Figures 10 and 11). AMP retention
by puriﬁed SdKefQCTD D436E and D436A proteins was
analyzed as described above, and it was observed that the D436E
protein retained almost the same levels of AMP as the wild type
whereas the D436A protein had only ∼20% of the normal level
(Figure 10). When AMP retention by R416E was analyzed by
HPLC, very little AMP could be detected (Figure 11).
Computational Analysis of the Eﬀect of Ligand
Binding on SdKefQCTD Stability. To investigate computa-
tionally the eﬀect of AMP and related ligands on protein stability,
molecular dynamics (MD) simulations were performed. To
include regions of the protein that are disordered in the X-ray
crystal structure, the SdKefQCTD homology model previously
reported by Healy et al.12 was employed. Four systems were
evaluated: (a) SdKefQCTD bound to one GSH molecule and
two AMP molecules (one bound to each of the Rossmann folds
in the dimer), (b) SdKefQCTD bound to one ESGmolecule and
two AMP molecules, (c) SdKefQCTD bound to one GSH
molecule, and (d) SdKefQCTD bound to one ESG molecule.
Consistent with the experimental data described above, MD
simulations of the systems with AMP bound to the Rossmann
fold were more stable than the same model without AMP [as
quantiﬁed by smaller per-residue ﬂuctuations (shown in Figure
12A,B)]. The SdKefQCTD−AMP−GSH complex did not show
Table 2. Protein Yields and Percentages of AMP Retention of
the D436E and D436A Mutants
S. denitrif icans Kef mutant protein yield (mg/L) AMP retention (%)
WT-FL 3 ± 1 107.3 ± 21.5 (n = 2)
WT-QCTD 9 ± 1 101.5 ± 11.6 (n = 2)
D436E-QCTD 8 ± 2 99.7 ± 23.2 (n = 2)
D436A-QCTD 2 ± 1 14.7 ± n/a (n = 1)
Figure 10. AMP percentage of retention calculated by comparing the absorption at 280 nm (A280) of the denatured proteins and AMP standards that
were run the same day, at equal concentrations, at equal sample volumes, and in identical buﬀers. A representative example is shown. Mutants D436A
and D436E were studied; 100 μL of a 200 μM sample was treated as described in Materials and Methods, and all resulting single peaks appearing in the
gel ﬁltration proﬁles were subjected to further mass spectrometry analysis for nucleotide identiﬁcation (Figure S5D−F).
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large conformational changes during the entire simulation. This
model had a stabilized root-mean-square deviation (RMSD),
relative to the initial point of theMD, of approximately 2.2 Å after
the ﬁrst 5 ns of MD (Figure 12C); the SdKefQCTD−AMP−
ESG complex stabilized after 25 ns of MD at an approximately
2.3 Å RMSD (Figure 12C). This behavior is predictable, because
the initial homology model was based on the EcKefQCTD X-ray
crystal structure with AMP and GSH both bound (PDB entry
3L9W), so some conformational changes are to be expected
upon substitution of GSH with ESG. In contrast, a 40 ns
Figure 11. HPLC analysis of AMP released from heat-denatured SdKefQCTD and SdKefQCTD(R416E). All experiments were conducted under the
sameHPLC conditions (seeMaterials andMethods for details). (A)HPLC proﬁle of 50 μMpure adenosinemonophosphate (AMP). (B)HPLC proﬁle
of 50 μMdenatured wild-type protein (WT)− SdKefQCTD. (C) Spiking experiment containing equal concentrations (25 μM each) of pure AMP and
denaturedWT (i.e., AMP +WT). (D) Quantiﬁcation of HPLC peak areas of panels A−C. Data shown are mean± standard deviation (SD) values from
three diﬀerent experiments (n = 3). (E) HPLC proﬁle of 8.6 μM pure AMP. (F) HPLC proﬁle of 8.6 μM denatured mutant protein (Mutant) −
SdKefQCTD(R416E). (G) Spiking experiment containing equal concentrations (4.3 μM each) of pure AMP and the denatured mutant (i.e., AMP +
Mutant). (H) Quantiﬁcation of HPLC peak areas of panels E−G. Data shown are mean ± SD values from three diﬀerent experiments (n = 3).
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simulation time was insuﬃcient to observe stability for
SdKefQCTD−GSH and SdKefQCTD−ESG complexes without
AMP bound, which displayed larger geometric ﬂuctuations, as
judged by RMSD values of >3 Å. These results are qualitatively
consistent with AMP being an important factor in stabilizing the
SdKefQCTD structure.
The AMP−R416 interactions (electrostatic and hydrogen
bonding) were maintained for 40 ns of MD, with one or two
hydrogen bonds observed throughout the simulation (see Figure
S13 for further information). Hydrogen bonding interactions at
the interface of the protein dimer (R416, E524, R503, and I505)
may help to provide structural rigidity. A 40 ns simulation of
SdKefQCTD bound only to ESG (Figure 12B) shows the high
ﬂexibility of the region containing Pro439−Leu445 residues, as a
result of unfavorable steric interactions with the succinimide ring
of ESG. This eﬀect is not observed in the SdKefQCTD−AMP−
ESG complex, because of hydrogen bonds with Asp436 (Figure
S14 and Figure 12B) and aromatic face-to-face (so-called π-
stacking) interactions with His437 (Figure S15). These
interactions are maintained during 40 ns of MD simulation and
increase the structural stability of the amino acids in the P439−
L445 region.
■ DISCUSSION
A combination of crystallography, DSF, HPLC analysis, MS, and
NMR studies provides evidence that the SdKefQCTD domain
binds AMP; HPLC analysis suggests the full-length protein also
binds AMP. The stoichiometry of the complex, determined using
MS and HPLC, is 1:1 (one AMP molecule per SdKefQCTD
monomer), which is consistent with that observed by
Figure 12. (A) Per-residue root-mean-square ﬂuctuations (RMSF) of the Cα atoms of a homologymodel of SdKefQCTD in the presence of either GSH
and AMP (blue) or only GSH (red). (B) Per-residue RMSF of the Cα atoms of a homology model of SdKefQCTD in the presence of either ESG and
AMP (green) or only GSH (yellow). (C) Temporal root-mean-square deviation (relative to the starting structure) for Cα atoms during a 40 ns MD
simulation for SdKefQCTD in complex with GSH (red), GSH and AMP (blue), ESG (purple), or ESG and AMP (green).
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crystallography. Although we were unable to measure a direct
binding constant, several pieces of evidence point to this being a
high-aﬃnity interaction, which we suggest is approximately in the
nanomolar range. First, it was possible to remove AMP only by
denaturing the protein and, second, the high degree of thermal
stabilization of SdKefQCTD by adding additional AMP; third,
we were not able to exchange AMP with related nucleotides, and
ﬁnally, the AMP must have been bound in the cytoplasm of E.
coli, where the concentration of AMP is much lower than those of
other adenosine-containing nucleotides. The estimated cellular
concentrations of relevant nucleotides in E. coli are 9 mM ATP,
0.5 mM ADP, 0.28 mM AMP, 2.6 mM NAD+, and 0.08 mM
NADH.22 AMP pools are integrated with those of ADP and ATP
via the activity of adenylate kinase. The E. coli adenylate kinase
has a high aﬃnity for AMP (∼30 μM) and a high Vmax [1247
μmol min−1 (mg of protein)−1], ensuring a rapid equilibrium.23
Thus, the growing cell maintains an ATP:ADP:AMP ratio of
100:10:2 (stationary phase cells generally have higher AMP
concentrations). We did not detect any protein with NAD+,
NADH, or ATP bound, which implies that in the cell the domain
has a binding constant for AMP at least 200-fold tighter than that
for NAD+, 6-fold tighter than that for NADH, 700-fold tighter
than that for ATP, and 35-fold tighter than that for ADP (these
values are predicated upon an estimated upper limit of 5% for
missed detection of such complexes). The observation that the
protein appears (within the error of our measurement) to be fully
occupied with AMP despite extensive puriﬁcation suggests a very
tight binding. It should be noted, however, that the observed Kd
value of the KtrAB system for nucleotides falls well below the
concentration of cellular pools,24 and it has been speculated that
the change in these pools is accompanied by nucleotide
exchanges that are intrinsic to the allosteric transition.
The Kef system is normally in an inactive, GSH-bound, state.
When GSH is replaced by an electrophilic adduct of GSH, this
triggers channel opening. The formation of such an adduct
occurs when the bacterial cell is intoxicated, and the activation of
the K+ eﬄux system is part of the survival response. In such a
scheme, what is the role of AMP? Dimeric Kef protein possesses
two GSH-binding sites that are located at the interface between
the two protein monomers. These sites are in the proximity of
the two nucleotide-binding sites, and in fact, complex series of
hydrogen bond and salt bridge interactions link AMP, the dimer,
and the residues that form the GSH-binding site (Figure 3). We
hypothesized that the GSH (and GSH adduct)-binding site
requires dimer formation, which in turn is dependent on the
presence of AMP. Thus, we propose AMP plays a vital role in
creating a protein architecture that can respond to the chemical
change induced by binding GSH adducts. Speciﬁcally, AMP
makes a number of contacts with helix 418−437 that extends
across the dimer interface and is thought to be involved in the
conformational change associated with Kef channel gating.
In support of this model, we note that addition of exogenous
AMP results in signiﬁcant stabilization of the protein, which is
much larger than typically expected for stabilization of a
monomeric protein alone. As SdKefQCTD always co-puriﬁes
with the bound nucleotide, we were unable to generate a true apo
structure to measure the stabilizing eﬀect of ESG on its own;
however, we noted its stabilization eﬀect was additive to AMP,
and NMR analysis conﬁrmed that ESG binding did not displace
AMP. Computational modeling was used to generate a structure
lacking bound AMP, and classical MD simulations showed lower
structural stabilities, even when GSH was added. By contrast,
models with AMP remained stable regardless of whether GSH
was present. Experimental conﬁrmation of the importance of
AMP binding for structural integrity was obtained by a panel of
mutants selected to disrupt AMP binding. In each case, the
mutants displayed a decrease in the AMP content of puriﬁed
protein, reduced stability, and loss of activity.
Previous crystallographic studies of KTN domains from
channels and transporters have identiﬁed a variety of bound
nucleotides. Usually, these have been ligands added during
crystallization rather than being carried through during
puriﬁcation, and in many cases, the apoprotein is readily isolated.
For the octameric assemblies, the crystallographic evidence of
the role of these speciﬁc nucleotides has been supported by
biochemical evidence. In contrast, for the determined structures
of the dimeric complexes, the observed density is consistent with
AMP, but crystallography on its own is not a deﬁnitive tool for
the identiﬁcation of ligands. For the E. coli KefC KTN domain
structures, density consistent with AMP was observed in two
crystal forms (the apoprotein and the GSH-bound form),
whereas a sulfate ion was found in the AMP-binding site in the
ESG-bound form. These structures have provided valuable
insight into the nature of the conformational change induced by
the electrophilic modiﬁcation of GSH. A KTN domain structure
with AMP has been deposited by a structural genomics
consortium (PDB entry 3C85), but no comment about what if
any ligands were added and the basis of ligand identiﬁcation is
available. Thus, it seems plausible that the dimeric KTNmodules
have AMP as a structural moiety, while the octameric proteins
have the nucleotides, most probably ATP and NADH, as
allosteric modulators of channel activity.
A further diﬀerence between the dimeric and octameric
assemblies is the recognition of additional ligands, such as GSH,
that regulate the activity of the dimeric systems, unlike in the
octamers where dissociation of the nucleotide is used to achieve
activation. In contrast to the other KTN domains (i.e., Trk, Ktr,
and potentially the channels) for which the nucleotide may play a
major role in gating, we propose AMP in Kef is required to form
the structure that binds GSH and its adducts. It follows,
therefore, that the aﬃnity for the gating ligands (whether
nucleotide or GSH) should be within the dynamic range of
actively metabolizing cells. While a stabilizing ligand should bind
suﬃciently tightly to ensure the integrity of the protein under all
metabolic states.
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